Major New Partnership &Update

Advanced Medical Solutions Grp PLC
13 July 2004


For Immediate Release                                07:00, Tuesday 13 July 2004


                      Advanced Medical Solutions Group plc
               Announce major new partnership and trading update
        AMS to Private Label Wound Care Products for Cardinal Health for
                               U.S. Distribution


Winsford, UK: Advanced Medical Solutions, (AIM: AMS), ('AMS' or the 'Company') a
global wound care technology company, today announced that it has entered into a
three-year agreement with Cardinal Health, a leading provider of products and
services supporting the health care industry in the United States, for private
label wound care products.

Under terms of the agreement, AMS will provide Cardinal Health with a range of
advanced wound care products, namely alginates, hydrocolloids, hydrogels and
foams beginning in July. The products will be privately labelled under Cardinal
Health's Allegiance(R) brand.

'We are seeing a significant trend in the market whereby major distributors are
looking to carry a range of standard private label wound care products. I am
delighted that we are able to partner with a distributor with the strength of
Cardinal Health,' said Dr. Don Evans, Chief Executive of AMS. 'As a focused
wound care technology company with a full range of products and materials, AMS
is ideally placed to provide a one-stop shop for these private label products,
complementing its programme of supplying new and differentiated products to its
major international partners under their leading brands.'

'We are pleased to be able to obtain a full range of quality advanced woundcare
products for the US market,' said Gary Kamees,Vice President of Global Sourcing
for Cardinal Health. 'Its strong research and development, manufacturing
capabilities and stringent quality control standards, makes AMS an excellent
technology partner for us to continue to build our private label business.'


                    Pre-close trading update

AMS is also pleased to update investors on trading ahead of the close period for
the half-year ending 30th June 2004.

Dr. Geoffrey Vernon, Chairman of AMS stated that: 'the outlook for the Group
remains positive at the half-year, with turnover continuing to show good growth
over previous year.   The Company continues to trade in line with market
expectations and remains on track to come through to profitability within
current cash'.

                                    - ENDS -


For further information, please contact:

Advanced Medical Solutions Group plc                  Tel : [phone]
Don Evans, Chie f Executive
Mary Tavener, Finance Director
www.admedsol.com

Buchanan Communications                               Tel: [phone]
Mark Court, Mary-Jane Johnson


Notes to Editors:

Advanced Medical Solutions is a leading company in the development and
manufacture of products for the $15 billion global woundcare market.

Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions is
focused on the design, development and manufacture of innovative and
technologically advanced products for woundcare and other medical applications.

In-house natural and synthetic polymer technology is used to provide advanced
wound dressings based on the moist healing principle. AMS's resources ensure a
unique position as a vertically integrated 'one stop shop' to provide all
categories of moist wound healing products. The Company has the capability to
move from product design and development through to production and delivery
ready for distribution into customer markets.

The acquisition of MedLogic in 2002 has brought AMS products and technology in
cyanoacrylate based tissue adhesives and sealants sold direct to hospitals or
through distributors.

AMS's technology and products currently serve the majority of the key global
markets with strategic partners including 3M, Novartis, Johnson & Johnson,
Molnlycke Healthcare, Coloplast, Smith + Nephew and Beiersdorf.


                      This information is provided by RNS
            The company news service from the London Stock Exchange